title: Pneumonia due to Candida krusei.
abstract: A case of post-transplantation pneumonia due to Candida krusei is reported. A 42-year-old man was admitted 28 days after heart transplantation with cough, pleuritic pain and fever. A chest computed tomograph showed multiple alveolar infiltrates bilaterally. He received broad-spectrum antibiotics, fluconazole for oral candidiasis, and cotrimoxazole for possible Pneumocystis carinii. A short-lived period of improvement was followed by respiratory failure. Cultures of bronchial washings grew C. krusei and C. albicans. The infection was documented by histology and culture obtained by transthoracic aspiration. Treatment with amphotericin B was initiated, but the patient died. Histology and culture of a pulmonary specimen, obtained immediately post mortem, further documented the infection with C. krusei.
authors.affiliation: Department of Clinical Therapeutics, University of Athens School of Medicine, Alexandra Hospital, Greece. filothei@nikolopoulou.gr
authors.forename: V
authors.initials: V
authors.lastname: Petrocheilou-Paschou
authors.forename: K
authors.initials: K
authors.lastname: Georgilis
authors.forename: D
authors.initials: D
authors.lastname: Kontoyannis
authors.forename: J
authors.initials: J
authors.lastname: Nanas
authors.forename: H
authors.initials: H
authors.lastname: Prifti
authors.forename: H
authors.initials: H
authors.lastname: Costopoulos
authors.forename: S
authors.initials: S
authors.lastname: Stamatelopoulos
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002175:Candida / Q000302:isolation & purification*; D002177:Candidiasis / Q000150:complications* / Q000188:drug therapy; D017809:Fatal Outcome; D015725:Fluconazole / Q000627:therapeutic use; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D011014:Pneumonia / Q000188:drug therapy / Q000382:microbiology*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000935:Antifungal Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D015725:Fluconazole